Fundraising FoxEnavate Sciences — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Sudo Biosudobio.comDec 2023
Sudo Biosciences develops small molecule therapeutics for neurological and immune-mediated inflammatory conditions.
BiotechHealthtechMedical DevicesMenlo Park, US
Jim Bristol(Director)Daniel Estes(Director)inScott Byrd(Executive Officer, Director)in
Co-investorsFrazier Life SciencesMonograph Capital PartnersMSA NovoPICUS CAPITALSanofi VenturesSV Health Investors+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.